×

Modulation of HIF1-beta expression

  • US 7,799,764 B2
  • Filed: 10/13/2009
  • Issued: 09/21/2010
  • Est. Priority Date: 08/25/2004
  • Status: Expired due to Fees
First Claim
Patent Images

1. A compound comprising a modified oligonucleotide consisting of 12 to 30 linked nucleosides and having a nucleobase sequence comprising at least 8 contiguous nucleobases of the nucleobase sequence recited in SEQ ID NO:

  • 30, wherein the nucleobase sequence of the modified oligonucleotide is at least 90% complementary to SEQ ID NO;

    4 as measured over the entirety of said modified oligonucleotide, wherein said compound inhibits expression of human HIF-1 beta.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×